IGFBP3 and Glucose intolerance: Animal experiments have shown that overexpression of human IGFBP-3 or its mutant devoid of IGF-binding ability leads to glucose intolerance with different effects on insulin secretion, insulin sensitivity, and lipid homeostasis in aging mice 55.